This prospective analysis substantiates previous reports on the RR of PCa for BRCA1 and BRCA2 mutation carriers from retrospective studies, and provides direct estimates of absolute PCa risk by family history and mutation characteristics. This evidence concerns the gene BRCA1 and posterior cortical atrophy.